No One Really Knows What’s Happening Next

  How clinical trials are being affected by Brexit   On June 23, 2016, the UK voted to withdraw from the European Union, raising many questions about the future of clinical trials. However, Brexit wasn’t the beginning of the conversation, and it certainly...

Skin Cancer: Drug Gives ‘40% Melanoma Survival’

According to a new article via BBC.com, “Four-in-10 patients with a deadly skin cancer were still alive after three years when given a drug to boost their immune system, a study suggests.  The trial gave 655 patients with melanoma the drug Pembrolizumab, which...